Enter Note Done

Session


UAN #: 0391-9999-19-059-L01-P
ASCLS P.A.C.E.®: 2.5
P.A.C.E. #:273-158-19
Track: +AAR08 - New Antimicrobial Agents (in vitro and in vivo Studies Prior to the Start of Clinical Therapeutic Studies/pre-Phase 2)
CE Hours: 2.5

Upon completion of this Symposium, the participant should be able to:

Discuss the key attributes of new antibacterial agents to treat Gram-positive infections

Describe the key attributes of new antibacterial agents to treat C. difficile infections

Explain the key attributes of new antibacterial agents to treat infections caused by non-tuberculosis mycobacteria

The goal of this session is to describe the key attributes of new antibacterial agents currently in development for the treatment of infections caused by Gram-positive, C. difficile or non-tuberculosis mycobacteria.
Track
Antimicrobial Agents and Resistance
Subtrack
AAR08 - New Antimicrobial Agents
AAR09 - Pharmacological Studies of Investigational Agents Pre-NDA
Course Level
Intermediate
Session Type
Symposium
Curated Itineraries
New Agents in Pipeline